Expression of serum miR-375 and islet function of newly diagnosed type 2 diabetic patients with liraglutide treatment
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To explore miR-375 expression level changes of newly diagnosed patients with type 2 diabetic after liraglutide treatment, and analyze the relationship between insulin resistance and functional changes in pancreatic islet β cells. Methods: A total of 30 patients of newly diagnosed type 2 diabetes were selected to examine the oral glucose tolerance test (OGTT), insulin, C peptide, haemoglobin A1C (HbA1c), weight, waist circumference, blood pressure and miR-375 expression level changes in serum before and after 12 weeks of liraglutide treatment. Data analysis was performed using paired t test and Wilcoxon signed rank test. Results: MiR-375 expression and HbA1c were decreased after liraglutide treatment (P < 0.05). Areas under the curve of blood glucose 0-30 min and 0-120 min were significant increased (P < 0.05). Conclusion: After liraglutide treatment, insulin resistance and functional changes in pancreatic islet β cells of diabetics were improved, it may be related to the decrease of miR-375 expression level in serum.

    Reference
    Related
    Cited by
Get Citation

胥 娟,王 尧,唐 伟,朱 琳,高 远.利拉鲁肽治疗初诊断2型糖尿病患者血清miR-375的表达及胰岛功能的相关分析[J].南京医科大学学报(自然科学版英文版),2015,(11):1590-1593.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 22,2015
  • Revised:
  • Adopted:
  • Online: November 30,2015
  • Published:
Article QR Code